Fennec Pharmaceuticals Inc. (FENC) |
| 9 0.15 (1.69%) 06-12 16:00 |
| Open: | 8.9 |
| High: | 9.2496 |
| Low: | 8.83 |
| Volume: | 250,906 |
| Market Cap: | 257(M) |
| PE Ratio: | -31.03 |
| Exchange: | NASDAQ Capital Market |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 12.21 |
| Resistance 1: | 10.45 |
| Pivot price: | 9.38 |
| Support 1: | 8.16 |
| Support 2: | 6.75 |
| 52w High: | 10.45 |
| 52w Low: | 5.65 |
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical firm. Its leading investigational drug in clinical development is PEDMARK, a specialized formulation of sodium thiosulfate. This treatment is designed to shield young cancer patients from hearing damage (ototoxicity) that can be induced by platinum-based chemotherapy. The company, which was founded in 1996, previously operated under the name Adherex Technologies Inc. before officially rebranding as Fennec Pharmaceuticals Inc. in September 2014. Its corporate headquarters are situated in Research Triangle Park, North Carolina.
| EPS | -0.290 |
| Book Value | 1.090 |
| PEG Ratio | 1.47 |
| Gross Profit | 1.354 |
| Profit Margin (%) | -16.42 |
| Operating Margin (%) | -0.79 |
| Return on Assets (ttm) | -5.9 |
| Return on Equity (ttm) | -52.7 |
Wed, 10 Jun 2026
FENNEC (NASDAQ: FENC) director receives fully vested options for 20,000 shares - Stock Titan
Wed, 10 Jun 2026
Fennec Pharmaceuticals (NASDAQ: FENC) director granted 20,000 stock options at $8.70 - Stock Titan
Wed, 10 Jun 2026
FENNEC (FENC) director Khalid Islam receives options on 25,000 shares - Stock Titan
Wed, 10 Jun 2026
FENNEC (FENC) director Chris Rallis receives fully vested option grant - Stock Titan
Wed, 10 Jun 2026
Fennec (NASDAQ: FENC) investors back directors, pay and new equity plans - Stock Titan
Wed, 10 Jun 2026
Fennec investors re-elect directors, approve auditor and pay - Stock Titan
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |